Related references
Note: Only part of the references are listed.Selective downregulation of the high-molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes - Differential regulation from nondiabetic subjects
Rita Basu et al.
DIABETES (2007)
Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2
Makoto Ishikawa et al.
CANCER SCIENCE (2007)
Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic hispanics and african-americans
Anthony J. G. Hanley et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Adiponectin as an anti-inflammatory factor
Noriyuki Ouchi et al.
CLINICA CHIMICA ACTA (2007)
Low adiponectin levels are associated with renal cell carcinoma: A case-control study
Themistoklis N. Spyridopoulos et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Adenomatous polyps of the colon
Joel S. Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
Herbert Tilg et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans
Reiko Nakashima et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Relation of alcohol use and smoking to glucose tolerance status in Japanese men
Y Sakai et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2006)
A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin
Yasuko Nakano et al.
JOURNAL OF LIPID RESEARCH (2006)
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Takashi Kadowaki et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Genetic polymorphism of cholesterol 7α-hydroxylase (CYP7A1) and colorectal adenomas:: Self Defense Forces Health Study
S Tabata et al.
CANCER SCIENCE (2006)
C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women
EK Wei et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome
Kazuo Hara et al.
DIABETES CARE (2006)
Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males
FM Fisher et al.
DIABETOLOGIA (2005)
Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: Evidence for participation of insulin resistance
S Otake et al.
CLINICAL CANCER RESEARCH (2005)
A phase I study of α-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer
A Ishikawa et al.
CLINICAL CANCER RESEARCH (2005)
Adiponectin and breast cancer risk
C Mantzoros et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Circulating adiponectin and endometrial cancer risk
L Dal Maso et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Adiponectin as a biomarker of the metabolic syndrome
M Ryo et al.
CIRCULATION JOURNAL (2004)
Adiponectin: Stability in plasma over 36 hours and within-person variation over 1 year
T Pischon et al.
CLINICAL CHEMISTRY (2003)
Plasma adiponectin concentrations in relation to endometrial cancer: A case-control study in Greece
E Petridou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women
R Kaaks et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Role of the insulin-like growth factor family in cancer development and progression
H Yu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)